1. Home
  2. HSIC vs BRKR Comparison

HSIC vs BRKR Comparison

Compare HSIC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSIC
  • BRKR
  • Stock Information
  • Founded
  • HSIC 1932
  • BRKR 1960
  • Country
  • HSIC United States
  • BRKR United States
  • Employees
  • HSIC N/A
  • BRKR N/A
  • Industry
  • HSIC Medical Specialities
  • BRKR Biotechnology: Laboratory Analytical Instruments
  • Sector
  • HSIC Health Care
  • BRKR Industrials
  • Exchange
  • HSIC Nasdaq
  • BRKR Nasdaq
  • Market Cap
  • HSIC 9.0B
  • BRKR 6.3B
  • IPO Year
  • HSIC 1995
  • BRKR 2000
  • Fundamental
  • Price
  • HSIC $74.67
  • BRKR $42.13
  • Analyst Decision
  • HSIC Buy
  • BRKR Buy
  • Analyst Count
  • HSIC 10
  • BRKR 12
  • Target Price
  • HSIC $79.30
  • BRKR $54.50
  • AVG Volume (30 Days)
  • HSIC 1.5M
  • BRKR 2.3M
  • Earning Date
  • HSIC 08-05-2025
  • BRKR 08-05-2025
  • Dividend Yield
  • HSIC N/A
  • BRKR 0.47%
  • EPS Growth
  • HSIC 8.11
  • BRKR N/A
  • EPS
  • HSIC 3.21
  • BRKR 0.52
  • Revenue
  • HSIC $12,669,000,000.00
  • BRKR $3,446,100,000.00
  • Revenue This Year
  • HSIC $4.28
  • BRKR $6.43
  • Revenue Next Year
  • HSIC $3.57
  • BRKR $4.21
  • P/E Ratio
  • HSIC $23.27
  • BRKR $80.87
  • Revenue Growth
  • HSIC 1.75
  • BRKR 14.84
  • 52 Week Low
  • HSIC $60.56
  • BRKR $34.10
  • 52 Week High
  • HSIC $82.49
  • BRKR $72.94
  • Technical
  • Relative Strength Index (RSI)
  • HSIC 68.83
  • BRKR 63.12
  • Support Level
  • HSIC $72.21
  • BRKR $40.71
  • Resistance Level
  • HSIC $75.34
  • BRKR $43.21
  • Average True Range (ATR)
  • HSIC 1.30
  • BRKR 1.70
  • MACD
  • HSIC 0.25
  • BRKR 0.37
  • Stochastic Oscillator
  • HSIC 88.35
  • BRKR 87.46

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: